NorthWest Biotherapeutics Inc (NWBO)

[SparkyATL]

This may be a dumb question but I will ask it anyways. My gut is telling me that at a high level the trial neither failed nor surpassed expectations, but falls somewhere in the middle that still has benefits to patients, will add tremendous value to our knowledge of cancer and how the body works, is a stepping stone in the right direction, but that needs explaining. So that’s where my question lays, is there any chance they are waiting on something outside of this trial to help support or reference in either a RA or paper? ie. results from some of these combo trials going on that may be using dcvax?? I’m in finance and understand finance, but will be the first to say I am no expert in medical trials, comparisons, etc